NCR101

· Nuwacell Biotechnologies Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NCR101, covering 2025-02-13 to 2025-02-13. Get the full timeline:

Most recent: Clinical Trial Update: A Trial to Evaluate the Safety, Tolerability and Preliminary Efficacy of NCR101 in the Treatment of Subjects With Interstitial Lung Disease [Phase 1, Phase 2]

See pricing